Jacobiopharma Details
Oct 13, 2019 20:30

Jacobiopharma Class 1 new drug JAB-3212 enters the clinic in China

Yesterday, the drug clinical trial registration and information publicity platform showed that Jacobiopharma registered to start its Phase I clinical study of its Class 1 new drug JAB-3312 for advanced solid tumor patients.

Source: eo company